Intrarenal dopamine deficiency leads to hypertension and decreased longevity in mice.
about
Renal dopaminergic system: Pathophysiological implications and clinical perspectivesSynthesis and secretion of renin in mice with induced genetic mutationsInhibition of cyclooxygenase-2 in hematopoietic cells results in salt-sensitive hypertensionGastrin stimulates renal dopamine production by increasing the renal tubular uptake of l-DOPA.Gastrorenal Axis.The Synergistic Roles of Cholecystokinin B and Dopamine D5 Receptors on the Regulation of Renal Sodium Excretion.The Renin-Angiotensin and Renal Dopaminergic Systems Interact in Normotensive HumansMiR-217 mediates the protective effects of the dopamine D2 receptor on fibrosis in human renal proximal tubule cells.The renal dopaminergic system: novel diagnostic and therapeutic approaches in hypertension and kidney disease.Single-nucleotide polymorphisms of the dopamine D2 receptor increase inflammation and fibrosis in human renal proximal tubule cells.The cooperative roles of the dopamine receptors, D1R and D5R, on the regulation of renal sodium transport.Increased mitochondrial activity in renal proximal tubule cells from young spontaneously hypertensive ratsA linear relationship between the ex-vivo sodium mediated expression of two sodium regulatory pathways as a surrogate marker of salt sensitivity of blood pressure in exfoliated human renal proximal tubule cells: the virtual renal biopsy.Novel role of sorting nexin 5 in renal D(1) dopamine receptor trafficking and function: implications for hypertension.The intrarenal renin-angiotensin and dopaminergic systems: control of renal sodium excretion and blood pressureDiagnostic tools for hypertension and salt sensitivity testing.Mechanisms of dopamine D(1) and angiotensin type 2 receptor interaction in natriuresis.The divergence, actions, roles, and relatives of sodium-coupled bicarbonate transportersDeficient dopamine D2 receptor function causes renal inflammation independently of high blood pressureEpidermal growth factor receptor inhibition slows progression of diabetic nephropathy in association with a decrease in endoplasmic reticulum stress and an increase in autophagyAtrial natriuretic peptide and renal dopaminergic system: a positive friendly relationship?Renal dopamine receptors, oxidative stress, and hypertension.New targets for treatment of diabetic nephropathy: what we have learned from animal models.Dopamine D₁-like receptors regulate the α₁A-adrenergic receptor in human renal proximal tubule cells and D₁-like dopamine receptor knockout mice.Role of nuclear factor erythroid 2-related factor 2 in the oxidative stress-dependent hypertension associated with the depletion of DJ-1Abnormalities in renal dopamine signaling and hypertension: the role of GRK4.Intrarenal dopamine modulates progressive angiotensin II-mediated renal injury.Inhibitors of 20-hydroxyeicosatetraenoic acid (20-HETE) formation attenuate the natriuretic effect of dopamine.The effects of Ins2(Akita) diabetes and chronic angiotensin II infusion on cystometric properties in mice.Atrial Natriuretic Peptide Stimulates Dopamine Tubular Transport by Organic Cation Transporters: A Novel Mechanism to Enhance Renal Sodium ExcretionRegulation of glomerulotubular balance. I. Impact of dopamine on flow-dependent transport.Intrarenal dopamine inhibits progression of diabetic nephropathy.Antihypertensive mechanisms of intra-renal dopamineDopamine D2 receptors' effects on renal inflammation are mediated by regulation of PP2A function.Renal dopamine and angiotensin II receptor signaling in age-related hypertension.Physiologic and pathophysiologic roles of cyclooxygenase-2 in the kidneyRenal rescue of dopamine D2 receptor function reverses renal injury and high blood pressureDopamine, the kidney, and hypertension.Upregulation of renal D5 dopamine receptor ameliorates the hypertension in D3 dopamine receptor-deficient mice.Dopamine regulates renal osmoregulation during hyposaline stress via DRD1 in the spotted scat (Scatophagus argus).
P2860
Q22241156-5447D781-1F6B-4668-A89B-3DDCB9D7B462Q26999938-507AE06F-23DE-48CF-A9D2-4F3576DDEFC3Q27331781-C7754EE4-8BD8-4F5C-B7B1-3841CC1D0912Q30275612-0D764144-F643-43B5-AAFF-F3F395F9D0EBQ30277035-AE1BF409-B523-43F0-950C-ED5B8565F1C0Q30277777-5EBA79BD-4F03-44B5-8CF9-FFE5E195245FQ30299944-4C1882C2-53C7-4A77-8E79-28D1FA331B04Q30300319-79B9DAB8-583F-4A5C-B32F-981B087408BCQ30360038-5D8E1153-BEC2-4C43-AF81-ACCDD0702E15Q30407715-8577AA05-5F78-40EF-A6F1-3C618FD6995AQ30408870-3A051BE9-A13C-4C74-953D-5EEA34D4B290Q30411075-7243A6FE-64F9-440A-BE50-322C285AEACAQ30412608-EF3394DA-C68B-4FFE-9E3C-138854D0A6F9Q30413337-FB899B65-6540-4485-9BBD-B3CFE7C71653Q30414541-9C709076-1888-48BA-BD05-098C31F98422Q30417367-01D5E1E5-1C1E-4525-8E7F-59AA49E75754Q30422595-76D6DF50-A2C5-4091-A194-40518CFF1D11Q30440948-89627D36-C3BC-4635-A0D9-4797493A6662Q31066975-8A6A8614-E5B7-415D-961C-A03B73AAF305Q33646704-B1FCC9C6-8800-4320-AB01-33DB63AE332DQ33821039-84272AB3-2B1B-49A2-8653-6299FF8F8403Q34367267-FCDEAE3D-CC60-47B8-936E-877DC00C8692Q34498964-54EBCC05-7F56-47CE-B7EC-EF190DAD188BQ34627596-A602B1A4-AD93-449E-8B81-D8C5D80A339EQ35611392-4EED7B0B-0DF2-4A6D-95FD-C1C93EEC1822Q35777041-5B3096DB-65F7-4456-8989-78D6BD133C60Q35849467-625BAE8B-A173-4361-963C-D2053290E4D4Q36007749-BD058DD7-6F84-4CE2-9EA8-80D18CD5E37EQ36024882-F39859AB-C889-445A-A391-63339601E869Q36071740-DFF98361-2428-4BAD-89F8-2BF00486F4C8Q36208875-BD44DEDA-6CED-4862-8B22-11180003025DQ36249732-45ECD108-92BB-4D1C-ACAF-EE6B00AC7810Q36296904-2BE2B657-8DA9-41AE-89A6-42DF0D94E102Q36480352-044192B1-C785-40CA-B722-6B7DBEE5E23EQ36527864-2231247D-13D9-43BF-AC7D-DC730FD0B41FQ37026066-564A6970-97A8-4388-A371-6CCB4AF2ED94Q37041512-74B5B450-AFF5-49F8-9242-983BA627B13FQ37092215-DC1F8CB4-7FCD-43BE-81C9-F28230E22B0CQ37193713-61F1E14C-0159-49C5-A6E5-69B511F06F67Q37421729-2C1CBB82-DD1E-44DA-BC87-1DB48359B668
P2860
Intrarenal dopamine deficiency leads to hypertension and decreased longevity in mice.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Intrarenal dopamine deficiency leads to hypertension and decreased longevity in mice.
@ast
Intrarenal dopamine deficiency leads to hypertension and decreased longevity in mice.
@en
type
label
Intrarenal dopamine deficiency leads to hypertension and decreased longevity in mice.
@ast
Intrarenal dopamine deficiency leads to hypertension and decreased longevity in mice.
@en
prefLabel
Intrarenal dopamine deficiency leads to hypertension and decreased longevity in mice.
@ast
Intrarenal dopamine deficiency leads to hypertension and decreased longevity in mice.
@en
P2093
P2860
P356
P1476
Intrarenal dopamine deficiency leads to hypertension and decreased longevity in mice.
@en
P2093
Guanqing Wu
Haichun Yang
Huiyong Yin
Ming-Zhi Zhang
Raymond C Harris
Shilin Yang
Suwan Wang
Xiaofeng Fan
P2860
P304
P356
10.1172/JCI57324
P407
P577
2011-06-23T00:00:00Z